Cangrelor - CISMeF

Preferred Label : Cangrelor;

NCIt definition : An inhibitor of the platelet adenosine diphosphate (ADP) P2Y12 receptor (P2Y12R), with antiplatelet activity. Upon administration, cangrelor selectively and reversibly binds to P2Y12R, and blocks the platelet signaling pathway. This inhibits the activation of the glycoprotein complex GPIIb/IIIa, fibrinogen binding to platelets and platelet adhesion and aggregation.;

UNII : 6AQ1Y404U7;

InChIKey : PAEBIVWUMLRPSK-IDTAVKCVSA-N;

CAS number : 163706-06-7;

Molecule name : AR-C69931MX;

Chemical formula : C17H25Cl2F3N5O12P3S2;

Codes from synonyms : 85;

Details

Origin ID

C76395;

UMLS CUI

C1121991;

CISMeF manual mappings
- Cangrelor (substance) [SNOMED CT concept]
See also inter- (CISMeF)
- Product containing cangrelor (medicinal product) [SNOMED CT concept]
Semantic type(s)
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Cangrelor (substance) [SNOMED CT concept]
- Product containing cangrelor (medicinal product) [SNOMED CT concept]
- cangrelor [ATC Code]
- cangrelor [MeSH concept]
- cangrelor [MeSH Supplementary Concept]
Validated automatic mappings to BTNT
- cangrelor [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- HemOnc Agent Terminology [NCIt concept]
has_salt_form
- Cangrelor Tetrasodium [NCIt concept]
is_free_acid_or_base_form_of
- Cangrelor Tetrasodium [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients